MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20253775

April 1, 2025

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g (按C₁₆H₂₈N₂O₄计)

化学药品

April 1, 2025

Company Information

Applicant Company

南京市高淳区淳溪街道镇兴路73号8幢

Manufacturing Company

湖北省武汉经济技术开发区海特科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath